Valuation: Anupam Rasayan India Ltd

Market Cap 138B 1.45B 1.26B 1.17B 1.08B 2.02B 2.06B 13.74B 5.4B 69.28B 5.45B 5.34B 229B P/E 2026
81.6x
P/E 2027 * 41x
Enterprise Value 143B 1.51B 1.3B 1.22B 1.12B 2.1B 2.13B 14.26B 5.6B 71.86B 5.66B 5.53B 238B EV / Sales 2026
6.55x
EV / Sales 2027 * 4.2x
Free-Float
16.06%
Yield 2026
0.12%
Yield 2027 * 0.16%
07-16 Anupam Rasayan India Ltd acquired Mates Visa Consultancy Private Limited for INR 0.01 million. CI
07-15 Anupam Rasayan India Limited Signs Letter Of Intent With BASQUEVOLT, S.A. For Potential Long-Term Supply Of Specialty Chemical Product Worth USD 300 Million CI
07-05 Tanfac Industries Limited announced that it expects to receive INR 1.734872962 billion in funding from Anupam Rasayan India Ltd, Alrox Enterprises Private Limited CI
06-11 Anupam Rasayan India Limited Commercialises ETFA Using Flow Chemistry CI
06-04 Crisil Places Anupam Rasayan Ratings on Watch Developing After Bliss GVS Acquisition Announcement MT
05-25 Anupam Rasayan India Ltd, Q4 2026 Earnings Call, May 25, 2026
05-23 Anupam Rasayan India Ltd Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
05-23 Anupam Rasayan India Limited Announces Resignation of Vishal Thakkar as Deputy Chief Financial Officer and Key Managerial Personnel, Effective May 23, 2026 CI
05-23 Anupam Rasayan India Ltd Recommends Final Dividend for the Financial Year 2025-26 CI
05-22 Anupam Rasayan India Ltd proposed to acquire 26.21% stake in Bliss GVS Pharma Limited for INR 8.3 billion. CI
05-22 Anupam Rasayan India Ltd proposed to acquire 26.21% stake in Bliss GVS Pharma Limited for INR 8.3 billion. CI
05-22 Anupam Rasayan India Ltd entered into a share purchase agreement to acquire 43.30% stake in Bliss GVS Pharma Limited for INR 13.7 billion. CI
02-27 Anupam Rasayan India Ltd completed the acquisition of Jayhawk Fine Chemicals Corporation from CABB Group GmbH. CI
1 day+0.13%
1 week+0.56%
Current month+0.56%
1 month-3.58%
3 months-11.48%
6 months-7.66%
Current year-7.91%
1 week 1,196
Extreme 1196
1,224
1 month 1,196
Extreme 1196
1,294.5
Current year 1,162.3
Extreme 1162.3
1,415
1 year 1,045.2
Extreme 1045.2
1,415
3 years 601
Extreme 601
1,415
5 years 546.75
Extreme 546.75
1,415
10 years 474
Extreme 474
1,415
Manager TitleAgeSince
Chief Executive Officer - 10/09/2023
Director of Finance/CFO 36 14/03/2022
Chief Operating Officer 54 22/02/2021
Director TitleAgeSince
Chairman 50 22/04/2013
Director/Board Member 52 31/12/1991
Chairman 77 30/08/2020
Change 5-day change 1-year change 3-year change Capi.($)
+0.13%+0.56%+8.40%+30.39% 1.45B
+0.60%+2.72%+4.51%+53.97% 79.94B
+1.41%+6.68%+0.52%-27.48% 38.53B
-0.50%+4.30%-0.80%+18.29% 38.5B
-16.55%-14.21%-6.98%+21.65% 24.53B
+0.73%+1.41%+28.53%+16.93% 24B
-0.69%+7.29%+70.42%+3.12% 20.55B
-1.10%+3.99%-32.61%-38.79% 19.24B
+4.54%+11.45%+73.70%-32.99% 15.47B
+0.80%+5.77%+7.36%+78.02% 14.81B
Average -1.06%+3.00%+15.30%+12.31% 27.7B
Weighted average by Cap. -0.93%+2.94%+10.63%+17.71%

Financials

2026 2027 *
Net sales 22.24B 234M 202M 189M 173M 326M 331M 2.21B 868M 11.14B 877M 858M 36.87B 37.23B 391M 338M 316M 290M 545M 554M 3.7B 1.45B 18.65B 1.47B 1.44B 61.72B
Net income 1.59B 16.69M 14.44M 13.48M 12.38M 23.27M 23.63M 158M 62.04M 796M 62.67M 61.31M 2.63B 3.37B 35.39M 30.62M 28.58M 26.24M 49.33M 50.1M 335M 132M 1.69B 133M 130M 5.58B
Net Debt 5.16B 54.19M 46.89M 43.76M 40.18M 75.54M 76.71M 513M 201M 2.58B 203M 199M 8.55B 18.21B 191M 165M 154M 142M 267M 271M 1.81B 711M 9.12B 718M 702M 30.18B
Logo Anupam Rasayan India Ltd
Anupam Rasayan India Ltd. is an India-based company, which is engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals. The Company's segments include Life Science related Specialty Chemicals and Other Specialty Chemicals. The Life Science related Specialty Chemicals segment includes agrochemicals (including crop protection), personal care, and pharmaceuticals businesses. Its agrochemicals business includes manufacturing agro intermediates and active ingredients, such as insecticides, fungicides, herbicides and plant growth regulators. Its personal care business manufactures antibacterial and ultraviolet protection intermediates. Its pharmaceuticals business develops intermediates and key starting materials for active pharmaceutical ingredients used in therapeutic segments, including cardiovascular and antidiabetic. The Other Specialty Chemicals segment includes specialty pigments, specialty dyes, and polymer additives. It caters to Indian and global customers.
Employees
2,606
Date Price Change Volume
07/08/26 ₹1,214.60 +0.13% 315,118
06/08/26 ₹1,213.00 -0.27% 88,592
05/08/26 ₹1,216.30 +0.16% 138,524
04/08/26 ₹1,214.40 +0.38% 234,655
03/08/26 ₹1,209.80 +0.17% 199,378
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
1,214.60INR
Average target price
1,143.00INR
Spread / Average Target
-5.89%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ANURAS Stock